Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (171-180 of 290) with videos related to

Pageof 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Journal of Human Genetics|October 19, 2025
Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphomaShimon Nakashima, Masataka Nakano, Tatsuki Fukami, et al.
British Journal of Haematology|April 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphomaTomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, et al.
Journal of Biochemistry|November 10, 2023
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradationMuneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, et al.
Cancer Science|June 26, 2003
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaKazuhisa Miura, Shinsuke Iida, Ichiro Hanamura, et al.
Cancer Science|March 25, 2022
Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.
International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.
Cancer Science|July 9, 2020
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.
British Journal of Haematology|April 26, 2017
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myelomaShotaro Tatekawa, Yoshiaki Chinen, Masaki Ri, et al.
Pageof 29

Showing results (171-180 of 290) with videos related to

Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Journal of Human Genetics|October 19, 2025
Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphomaShimon Nakashima, Masataka Nakano, Tatsuki Fukami, et al.
British Journal of Haematology|April 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphomaTomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, et al.
Journal of Biochemistry|November 10, 2023
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradationMuneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, et al.
Cancer Science|June 26, 2003
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaKazuhisa Miura, Shinsuke Iida, Ichiro Hanamura, et al.
Cancer Science|March 25, 2022
Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.
International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.
Cancer Science|July 9, 2020
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.
British Journal of Haematology|April 26, 2017
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myelomaShotaro Tatekawa, Yoshiaki Chinen, Masaki Ri, et al.
Pageof 29